Fig. 7From: SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− miceHeart vessel area fraction was not significantly different between treated and untreated ob/ob−/− mice (n = 11 per group). Data analyzed using two-tailed Mann–Whitney test, and are presented as mean with standard deviationBack to article page